Regeneron Pharmaceuticals operates a network of specialized facilities across the United States, focusing on the research, development, and manufacturing of innovative biopharmaceuticals. Understanding the specific Regeneron locations is essential for partners, investors, and patients who need to engage with the company’s operations, whether for clinical trials, medical affairs, or corporate collaboration.
Primary Corporate Headquarters and Global Hub
The central command for Regeneron is situated in Tarrytown, New York, serving as the primary hub for executive leadership and global strategy. This location houses the main research laboratories and administrative offices that drive the company’s pipeline forward. The Tarrytown campus is a focal point for scientific innovation, hosting multidisciplinary teams dedicated to discovering breakthrough therapies.
Research and Development Facilities Rensselaer, New York Located in the Rensselaer Technology Park, this state-of-the-art facility is a cornerstone of Regeneron’s scientific endeavors. The Rensselaer location is heavily involved in cutting-edge research, particularly in the fields of neuroscience and ophthalmology, leveraging advanced technologies to accelerate drug discovery. Durham, North Carolina Regeneron’s Durham site is a critical center for research and development, specializing in immunology and inflammation. This location allows the company to tap into a rich academic and biotech ecosystem, fostering collaborations that drive the development of treatments for complex diseases. Manufacturing and Supply Chain Operations
Rensselaer, New York
Located in the Rensselaer Technology Park, this state-of-the-art facility is a cornerstone of Regeneron’s scientific endeavors. The Rensselaer location is heavily involved in cutting-edge research, particularly in the fields of neuroscience and ophthalmology, leveraging advanced technologies to accelerate drug discovery.
Durham, North Carolina
Regeneron’s Durham site is a critical center for research and development, specializing in immunology and inflammation. This location allows the company to tap into a rich academic and biotech ecosystem, fostering collaborations that drive the development of treatments for complex diseases.
To ensure the reliable delivery of life-saving medications, Regeneron maintains dedicated manufacturing facilities. One key location handles the production of active pharmaceutical ingredients (APIs) and finished drug products, adhering to strict regulatory standards. These operations are vital for translating laboratory discoveries into tangible patient treatments.
Clinical Development and Medical Affairs
Regeneron operates clinical research units and medical affairs offices in various strategic locations to facilitate global trials and provide scientific expertise. These hubs are staffed by specialized professionals who manage the clinical development process, ensuring compliance and optimizing the path to regulatory approval.
Engaging with Regeneron Locations
Stakeholders looking to connect with specific Regeneron departments can refer to the following summary of key operational centers and their primary functions.
